Jeffry Simko

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Renal tumors harboring FLCN mutations: Case series from clinical practice

  Human Pathology · 2026-04-16 · 2 citations

• Abstract 1237: Effects of a home-based walking intervention on serum metabolomic profiles in men with prostate cancer on active surveillance.

  Cancer Research · 2026-04-03

• Abstract 3826: Systematic assessment of histomorphologic and immunohistochemical features in metastatic castration-resistant prostate cancer biopsies

  Cancer Research · 2026-04-03

• The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202

  Advances in Radiation Oncology · 2026-03-10

• 781 Immunohistochemistry Outperforms Next-Generation Sequencing in Detecting Mismatch Repair Deficiency in Prostate Carcinoma

  Laboratory Investigation · 2026-03-01

• 295 PSMA Staining in FNA Biopsies of Metastatic Prostate Cancer

  Laboratory Investigation · 2026-03-01

• Whole-Slide Telepathology Grading of Prostate Cancer in Biopsies Using International Society of Urological Pathology Criteria: Interobserver and Intraobserver Concordance and Implications for Active Surveillance

  The Journal of Urology · 2025-12-29

• Correlation of lymphocytic infiltration and degree of pleomorphism with tumor mutation burden in high-grade urothelial carcinoma

  Human Pathology · 2025-12-05

• Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials

  European Urology · 2025-12-01 · 4 citations

• Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence

  Histopathology · 2025-10-31 · 2 citations

• In reply to: ‘Prostate cancer with favorable histology is not synonymous with prostate cancer indolence’

  Histopathology · 2025-10-16 · 1 citations

• Abstract IA012: The NCTN biospecimen banks resource

  Cancer Epidemiology Biomarkers & Prevention · 2025-09-18

• Hyperpolarized [1-13C]pyruvate to [1-13C]lactate Conversion Rate with mpMRI to Distinguish Pathologically Aggressive Prostate Cancer

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies

  Histopathology · 2025-08-05 · 4 citations

• Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

  The Prostate · 2025-07-21

• Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

  European Urology Oncology · 2025-07-17 · 3 citations

• Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort

  European Urology Focus · 2025-05-14 · 4 citations

• Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials

  JCO Clinical Cancer Informatics · 2025-05-01 · 6 citations

• Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

  Journal of Clinical Oncology · 2025-04-16 · 21 citations

• 786 Clinical and Morphological Characterization of RAS/RAF/MAPK-Mutated Prostatic Adenocarcinoma

  Laboratory Investigation · 2025-03-01